What is Imidapril hydrochloride used for?
In the pharmaceutical industry, Imidapril Hydrochloride is a potent, long-acting ACE (Angiotensin-Converting Enzyme) inhibitor. As a pharmacist, I classify this as a “pro-drug”—it is inactive when swallowed and must be metabolized by the liver into its active form, imidaprilat, to exert its therapeutic effect.
Primary Clinical Uses
Hypertension (High Blood Pressure): It is primarily used to treat essential hypertension. It is particularly valued because it provides 24-hour blood pressure control with a single daily dose.
Congestive Heart Failure (CHF): Used as an adjunctive therapy to reduce the workload on the heart, improving exercise tolerance and long-term outcomes.
Renal Protection (Diabetic Nephropathy): Like other ACE inhibitors, it is often prescribed to protect kidney function in diabetic patients by reducing intraglomerular pressure.
Mechanism of Action
Imidapril works by interrupting the Renin-Angiotensin-Aldosterone System (RAAS), which is the body’s primary regulator of blood pressure.
Enzyme Inhibition: Imidaprilat inhibits the ACE enzyme, which normally converts Angiotensin I into the potent vasoconstrictor Angiotensin II.
Vasodilation: By reducing Angiotensin II levels, blood vessels relax and widen (vasodilation), which lowers peripheral vascular resistance.
Aldosterone Reduction: It also decreases the secretion of aldosterone, leading to reduced sodium and water retention by the kidneys.
Bradykinin Potentiation: It inhibits the breakdown of bradykinin (a vasodilator), further contributing to its blood-pressure-lowering effect.
The Manufacturer’s Perspective: Formulation & Export
From a manufacturing and global trade standpoint, Imidapril is a high-precision cardiovascular product:
Low Incidence of “ACE Cough”: Clinical data suggests that Imidapril may have a lower incidence of the persistent dry cough typically associated with other ACE inhibitors (like Enalapril). As a firm owner, this is a major unique selling proposition (USP) for your digital marketing and export proposals.
API Stability: Imidapril is sensitive to moisture and heat. As a WHO-GMP manufacturer, we utilize Alu-Alu blister packaging to ensure a 36-month shelf life, which is essential for maintaining efficacy during export to Zone IVb regions (Africa, SE Asia).
Fixed-Dose Combinations (FDCs): Imidapril is often manufactured in combination with diuretics like Hydrochlorothiazide. These FDCs are highly sought after in B2B markets for improving patient compliance.
Dossier Support: Our Mumbai facility provides the CTD/eCTD Dossiers and stability data required to register this product in international markets against the innovator (Tanatril).